Welcome to the Institute of Clinical Research
Welcome to the Institute of Clinical Research
About Us
The Institute of Clinical Research (ICR) is the probably the oldest independent membership-led professional body for global clinical researchers.
For over 40 years, The Institute of Clinical Research (ICR) has provided high quality training, networking and support to the clinical research community. For many Members the Institute has been part of their life throughout their working careers, many have been with the Institute since its first incarnation as the ACRPI.
It is the membership that makes the Institute.
How does it all work ?
The Institute of Clinical Research is you, the Membership governed by the Articles of Memorandum drawn up by the founding members.
The Board is made up of members who give their time freely to guide the future direction of the ICR.
The ICR Secretariat is the administrative arm of the Institute, its primary focus is to ensure that the wishes of the Board and Membership are carried out and to see to the day to day tasks that any membership organisation generates.
Our Mission
The ICR exists to support our members through all stages of their careers. We do this, in part, by:
- Defining and refining standards for our profession
- Providing a forum for discussion of key issues impacting clinical research
- Promoting good relations with other healthcare related groups
- Providing opportunities for learning and development to enhance professional competence
- Enhancing public confidence and understanding of clinical research
Current News
Site Enablement: How Sponsors and CROs Can Enhance Their Clinical Trials in a Competitive Landscape
The evolution of clinical research has been dependent on the conversion of Healthcare Organizations (HCOs) to clinical research sites, along with the …
Opening doors
Following in their footsteps – the young people choosing to follow their parents into the pharmaceutical industry
Pharma has changed a lot in recent y…
J&J to phase out Janssen name in corporate rebrand
Janssen, a brand name that for six decades has been emblazoned on Johnson & Johnson’s pharmaceutical laboratories and prescription drugs, will be …
NICE gives green light for MSD's Keytruda
The decision is the first verdict based on data from a wider immunotherapy ‘basket’ study
MSD has revealed that the National Institute for Health and …
Biogen kicks off 1,000 layoffs as part of CEO Chris Viehbacher's 'complete redesign'
It was only last spring that Biogen started a round of layoffs that eventually shrank the company’s head count by nearly 900 people last year. Now, a …
Men with enlarged prostates offered robotic treatment by fourth University Hospital
Aquablation is a robotic method that uses a high-pressure saline solution to remove tissue
The Norfolk and Norwich University Hospitals (NNUH) Urology…
Autumn Ethics & GCP Forum - ONLINE - Friday 17th November 2023
To book via Eventbrite and see the full agenda visit our Website
If you have any questions please email office@icr-global.org
Green light for one of Europe’s largest life sciences campus
Reef Group and UBS Asset Management have gained approval to develop one of Europe’s largest life sciences campuses in Stevenage, UK.
Family of Henrietta Lacks sues Ultragenyx over use of HeLa cell line
The family of Henrietta Lacks is suing rare disease drug developer Ultragenyx over its use of technology built from her cells, which were taken withou…
Cannabinoid company expands into oncology
Oxford Cannabinoid Technologies Holdings (OCTP) – the company developing prescription cannabinoid medicines – is expanding its research and developmen…
Build a More Participant-Focused Trial: Amplify the Patient Voice in Clinical Research Technology Development
For those of us who use sophisticated digital tools every day, it’s easy to assume that technology always makes life easier. It doesn’t.
TauRx’s deliver Alzheimer’s disease therapy results
TauRx Pharmaceuticals – a company focused on Alzheimer’s disease (AD) research – has announced results from its pivotal phase 3 LUCIDITY trial.
The st…
Improving the Patient Experience Through Research-Driven Design
Digital technologies designed to support clinical trial management have evolved greatly over the years, spurred by increasing complexity in study desi…
FDA grants Eisai’s Leqembi full approval, opening door to wider use of Alzheimer’s drug
On Thursday, the Food and Drug Administration awarded a full approval to the Alzheimer’s disease treatment Leqembi, a decision expected to significant…
How to Harmonize and Interpret the Tsunami of Sensor Data in Clinical Trials
The surge of wearable sensors is transforming the clinical trial experience for patients, sponsors, and research sites. Sensors can be worn by the pat…
Oh my, it’s AI!
How can we create trust in AI across the vast pharmaverse?
The proliferation of AI/ChatGPT resources during the initial months of 2023 has raised seve…
'The Top Line': The American Diabetes Association's annual conference, plus this week's headlines
In this episode of "The Top Line," we talk with Fierce’s Andrea Park and Gabrielle Masson about the latest from the American Diabetes Association's an…
With FDA approval in hand, BioMarin lays out plan to sell $2.9M gene therapy
BioMarin Pharmaceutical, having secured a long-awaited approval from the Food and Drug Administration, says its focus has now turned to launching its …
Eli Lilly's Mounjaro is primed to overtake Novo Nordisk's popular diabetes and obesity duo: report
In the battle for superiority in the field of next-gen diabetes and obesity treatments, Novo Nordisk holds the lead as the developer of the metabolism…
FDA delays decision on GSK bone cancer drug acquired in $2B buyout
- The Food and Drug Administration has delayed an approval decision for an experimental drug GSK is developing for a type of bone marrow cancer, so it …
MARKETING 'Scrolling Therapy' for Eurofarma by Dentsu Creative nabs Cannes Lions Pharma Grand Prix as traditional players lose out, again
Last year, the top winners at the prestigious Pharma Lions event at Cannes were not in fact pharma companies, and in 2023 that trend continues as a di…
Useful Downloads
Events and Courses
Clinical Investigations for Medical Devices - Foundation M2
In this one day course we explore clinical investigations for medical devices. We will review the latest legi...
Effective Project Management for Clinical Trials (3 Days ) M29
This practical course provides delegates with basic project management techniques that can be applied to clinical trial project management. Learning i...
Statistics for Non-Statisticians M31
Statistics is the art and science of summarising data. Statistics play an essential role in all stages of clinical research ...
Foundation in Good Clinical Practice (GCP) M22
Clinical trials play a pivotal role in progressing medical knowledge and enhancing patient care. However, as they engage real...
Essentials of Clinical Trial Monitoring M32
This practical course defines the role of the clinical research monitor and explains the interaction with others in key roles as part of the clinical ...
GCP for Experts M27
Please email office@icr-g...
Current Jobs
Quick Links
The oldest independent membership-led professional body for clinical researchers across the globe.
Latest Posts
- Site Enablement: How Sponsors and CROs Can Enhance Their Clinical Trials in a Competitive Landscape 19/09/2023 10:36 AM
- Opening doors 19/09/2023 10:34 AM
- J&J to phase out Janssen name in corporate rebrand 19/09/2023 10:33 AM
Useful Links
Contact Us
Registered office
11 Lyons Walk
Shaftesbury
Dorset
SP7 8JF
office@icr-global.org
Copyright © 2020 The Institute of Clinical Research. All Rights Reserved. Privacy Policy | Terms of Service